SCHMIDT ANN MARIE has a total of 12 patent applications. Its first patent ever was published in 2004. It filed its patents most often in United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are SHENZHEN IONOVA LIFE SCIENCE CO LTD, DJAMGOZ MUSTAFA BILGIN ALI and MAVUPHARMA INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 12 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry | |
#4 | Measurement | |
#5 | Agriculture |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Heterocyclic compounds | |
#4 | Peptides | |
#5 | Microorganisms | |
#6 | Analysing materials | |
#7 | Measuring microorganism processes | |
#8 | Animal care |
# | Name | Total Patents |
---|---|---|
#1 | Schmidt Ann Marie | 12 |
#2 | Rai Vivek | 4 |
#3 | Ramasamy Ravichandran | 4 |
#4 | Manigrasso Michaele B | 4 |
#5 | Shekhtman Alexander | 4 |
#6 | Stern David M | 2 |
#7 | Hudson Barry | 2 |
#8 | Stern David | 1 |
#9 | Ferrante Anthony | 1 |
#10 | Song Fei | 1 |
Publication | Filing date | Title |
---|---|---|
US2015094307A1 | Amino, amido and heterocyclic compounds as modulators of rage activity and uses thereof | |
US2013022620A1 | Assays and methods pertaining to pre-amyloid intermediates | |
US2013064835A1 | Rage regulates rock activity in cardiovascular disease | |
US2011311448A1 | Antibody to rage and uses for in vivo imaging or for targeting therapy | |
US8067371B2 | RAGE G82S-related methods and compositions for treating inflammatory disorders |